Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Invest Ophthalmol Vis Sci ; 63(9): 21, 2022 08 02.
Article in English | MEDLINE | ID: mdl-35980646

ABSTRACT

Purpose: The superior and inferior tarsal muscles are sympathetically innervated smooth muscles. Long-term diabetes often leads to microvascular complications, such as, retinopathy and autonomic neuropathy. We hypothesized that diabetes induces (1) sympathetic paresis in the superior and inferior tarsal muscles and that this measure is associated with (2) the severity of diabetic retinopathy, (3) the duration of diabetes, and (4) autonomic function. In addition, association between the severity of retinopathy and autonomic function was investigated. Methods: Forty-eight participants with long-term type 1 diabetes and confirmed distal symmetrical polyneuropathy were included. Palpebral fissure heights were measured bilaterally in response to topically applied 10% phenylephrine to the right eye. The presence of proliferative diabetic retinopathy (PDR) or nonproliferative diabetic retinopathy and disease duration were denoted. Time and frequency derived heart rate variability parameters obtained from 24-hour continuous electrocardiography were recorded. Results: The difference in palpebral fissure heights between phenylephrine treated and untreated eyes (∆PFH) was 1.02 mm ± 0.29 (P = 0.001). The ∆PFH was significantly lower in the PDR group (0.41 mm ± 0.43 vs. 1.27 mm ± 1.0), F(1,35) = 5.26, P = 0.011. The ∆PFH was lower with increasing diabetes duration, r(37) = -0.612, P = 0.000. Further, the ∆PFH was lower with diminished autonomic function assessed as total frequency power in electrocardiogram (r = 0.417, P = 0.014), and sympathetic measures of very low (r = 0.437, P = 0.010) and low frequency power (r = 0.384, P = 0.025). Conclusions: The ∆PFH is a simple ambulatory sympathetic measure, which was associated with the presence of PDR, disease duration, and autonomic function. Consequently, ∆PFH could potentially be an inexpensive and sensitive clinical indicator of autonomic dysfunction.


Subject(s)
Autonomic Nervous System Diseases , Diabetes Mellitus, Type 1 , Diabetic Neuropathies , Diabetic Retinopathy , Polyneuropathies , Autonomic Nervous System Diseases/complications , Autonomic Nervous System Diseases/etiology , Diabetes Mellitus, Type 1/complications , Eyelids , Humans , Phenylephrine/pharmacology
2.
Basic Clin Pharmacol Toxicol ; 126(6): 492-497, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31880065

ABSTRACT

Macular oedema is a known side effect to fingolimod, but changes in specific areas of the retina are only sparsely described. Our aim was to investigate the prevalence of macular oedema and characterize macular changes after initiation of fingolimod based on routine ophthalmological examinations in all consecutive patients treated at our hospital. We evaluated macular thickness change from baseline to 3-4 months after initiation of treatment. Central retinal thickness, total macular volume, total macular thickness, average thickness and inner-/outer macular thickness were automatically measured using optical coherence tomography (OCT). A total of 190 eyes completed the study, and none of those developed visible macular oedema. All macular areas showed a small, but statistically significant increase in thickness. Total macular volume increased by a mean of 0.05 mm3 (P = <.001). Mean best-corrected visual acuity only changed by .03 (P = .074). We observed a minimal change in macular thickness and no clinically relevant affection on visual acuity after 3-4 months of fingolimod treatment. Thus, our results do not underpin the need for routine screening for macular oedema in asymptomatic MS patients without diabetes or uveitis receiving 0.5 mg fingolimod daily.


Subject(s)
Fingolimod Hydrochloride/administration & dosage , Macula Lutea/pathology , Macular Edema/epidemiology , Multiple Sclerosis/drug therapy , Adult , Female , Fingolimod Hydrochloride/adverse effects , Humans , Macula Lutea/diagnostic imaging , Macula Lutea/drug effects , Macular Edema/chemically induced , Macular Edema/diagnostic imaging , Macular Edema/pathology , Male , Multiple Sclerosis/diagnostic imaging , Multiple Sclerosis/epidemiology , Retina/drug effects , Retina/pathology , Tomography, Optical Coherence , Visual Acuity
3.
J Diabetes Complications ; 33(4): 323-328, 2019 04.
Article in English | MEDLINE | ID: mdl-30733057

ABSTRACT

AIMS: Emerging evidence shows, that distal symmetric peripheral neuropathy (DSPN) also involves alterations in the central nervous system. Hence, the aims were to investigate brain metabolites in white matter of adults with diabetes and DSPN, and to compare any cerebral disparities with peripheral nerve characteristics. METHODS: In type 1 diabetes, brain metabolites of 47 adults with confirmed DSPN were compared with 28 matched healthy controls using proton magnetic resonance spectroscopy (H-MRS) in the parietal region including the sensorimotor fiber tracts. RESULTS: Adults with diabetes had 9.3% lower ratio of N-acetylaspartate/creatine (NAA/cre) in comparison to healthy (p < 0.001). Lower NAA/cre was associated with lower sural (p = 0.01) and tibial (p = 0.04) nerve amplitudes, longer diabetes duration (p = 0.03) and higher age (p = 0.03). In addition, NAA/cre was significantly lower in the subgroup with proliferative retinopathy as compared to the subgroup with non-proliferative retinopathy (p = 0.02). CONCLUSIONS: The association to peripheral nerve dysfunction, indicates concomitant presence of DSPN and central neuropathies, supporting the increasing recognition of diabetic neuropathy being, at least partly, a disease leading to polyneuropathy. Decreased NAA, is a potential promising biomarker of central neuronal dysfunction or loss, and thus may be useful to measure progression of neuropathy in diabetes or other neurodegenerative diseases.


Subject(s)
Aspartic Acid/analogs & derivatives , Brain/diagnostic imaging , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/metabolism , Diabetic Neuropathies/metabolism , Adult , Aspartic Acid/analysis , Aspartic Acid/metabolism , Brain/metabolism , Brain Chemistry , Case-Control Studies , Diabetes Mellitus, Type 1/diagnosis , Diabetes Mellitus, Type 1/pathology , Diabetic Neuropathies/diagnosis , Diabetic Neuropathies/pathology , Disease Progression , Female , Humans , Magnetic Resonance Spectroscopy , Male , Middle Aged , Peripheral Nerves/diagnostic imaging , Peripheral Nerves/metabolism , Polyneuropathies/complications , Polyneuropathies/diagnosis , Polyneuropathies/metabolism , Polyneuropathies/pathology , White Matter/chemistry , White Matter/metabolism
4.
Can J Ophthalmol ; 51(3): 207-11, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27316271

ABSTRACT

PURPOSE: To address the use of and knowledge about skills assessment and competency-based training in cataract surgery in European Board of Ophthalmology (EBO) member countries. METHODS: A survey was emailed directly to all directors of the European societies in ophthalmology. The survey included queries about criteria to undergo training in cataract surgery, regulation of education in cataract surgery, and skills assessment and training methods. In addition, all Danish Eye Departments were further asked to what extent they find assessment tools useful, if competency-based training in cataract surgery would be an improvement, and if an assessment tool would be considered for use in future training of cataract surgeons. RESULTS: Training in cataract surgery in EBO countries is very diverse; although some EBO countries consider it mandatory in residency, most do not. In EBO countries where training is mandatory and regulated by the local health authority, the use of skills assessment tools and competency-based education are more prevalent (e.g., U.K., Ireland, Switzerland, and the Netherlands). In Denmark, training in cataract surgery is not mandatory, and none of the eye departments used assessment scores to evaluate their trainees; 63% did not believe that using assessment tools would improve the outcome of surgical training, and less than one-third would consider frequent use of assessment tools in the future. CONCLUSION: General unawareness and scepticism toward objective structured assessment of technical skills and a considerable heterogeneity in concept and organization of training in cataract surgery across EBO countries is an issue to address.


Subject(s)
Cataract Extraction/education , Clinical Competence/standards , Competency-Based Education/standards , Education, Medical, Graduate/standards , Educational Measurement , Societies, Medical/organization & administration , Specialty Boards/standards , Adult , European Union , Health Care Surveys , Humans , Internship and Residency , Ophthalmology/education , Ophthalmology/organization & administration
5.
Ugeskr Laeger ; 177(8)2015 Feb 16.
Article in Danish | MEDLINE | ID: mdl-25697172

ABSTRACT

Melanoma of the choroid is the most frequent primary intra-ocular malignancy whereas a varix of the vortex vein ampulla is a benign, rare and asymptomatic condition requiring no treatment. A varix of the vortex vein ampulla is usually found accidentally and can easily be mistaken for a choroidal melanoma, a naevus or a haemorrhage. We present a case of a varix of the vortex vein ampulla, which can be distinguished from other more serious conditions by using simple clinical methods.


Subject(s)
Choroid/blood supply , Varicose Veins/diagnosis , Adult , Choroid Neoplasms/diagnosis , Diagnosis, Differential , Fluorescein Angiography , Humans , Indocyanine Green , Male , Melanoma/diagnosis , Tomography, Optical Coherence
6.
Ugeskr Laeger ; 164(24): 3180-4, 2002 Jun 10.
Article in Danish | MEDLINE | ID: mdl-12082762

ABSTRACT

Screening for diabetic retinopathy was introduced in Denmark in 1988. At present, screening is carried out in four of the 14 counties, thus being available to a minority of diabetic subjects. According to the WHO but also the National Board of Health, all diabetic patients should undergo screening for diabetic retinopathy. Not only does screening pay off in terms of preservation of vision, it is also cost-effective, as confirmed in the present study. The first fully digitized clinic for retinopathic screening in diabetic patients was recently introduced in the County of North Jutland. Preliminary results from this clinic indicate that all procedures can be handled in this fully digitized system. We therefore predict that fully digitized clinics for retinopathic screening will be introduced throughout Denmark in the future.


Subject(s)
Diabetic Retinopathy/diagnosis , Diagnosis, Computer-Assisted/methods , Fluorescein Angiography/methods , Mass Screening/methods , Telemedicine/methods , Denmark , Diabetic Retinopathy/complications , Diabetic Retinopathy/prevention & control , Hospital Units/organization & administration , Humans , Image Processing, Computer-Assisted/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...